PDK3驱动结直肠癌发生和免疫逃避,是促进免疫疗法的治疗标
Zhiqiang Liu1, Liang Li2, Lei Liu3
1Department of Neurology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College Nanchang 330006, Jiangxi, China.
American journal of cancer research
|July 15, 2024
概括
酸盐脱酶激酶3 (PDK3) 通过激活PI3K-AKT信号传递和PD-L1表达来促进结肠癌,同时抑制CD8+T细胞免疫力. 抑制PDK3可以增强抗瘤T细胞的反应,改善治疗结果.
科学领域:
- 在瘤学瘤学.
- 癌症免疫学 癌症免疫学
- 分子生物学分子生物学
背景情况:
- 酸盐脱酶激酶3 (PDK3) 与各种癌症有关,但其在结肠癌中的作用及其与免疫微环境的相互作用尚未完全理解.
- 了解PDK3的功能对于开发结直肠癌向疗法至关重要.
研究的目的:
- 研究PDK3在结肠癌扩散,免疫逃避以及其作为治疗点的潜力的作用.
- 在临床前结肠癌模型中探索PDK3抑制和PD-1阻断的联合疗效.
主要方法:
- 对TCGA数据进行全癌症分析,以评估PDK3表达和免疫微环境组成.
- 对结肠癌细胞进行体外研究,以检查PDK3对信号通路和免疫标记物的作用.
- 使用小鼠瘤模型进行体内实验,以评估单独抑制PDK3和与PD-1阻断结合的治疗潜力.
主要成果:
- 在结直肠癌中,PDK3的表达很高,通过PI3K-AKT信号促进增殖,并通过抑制抗原呈现和CD8+T细胞透来抑制抗瘤免疫力.
- PDK3促进STAT1的激活,并对结肠癌细胞中的PD-L1表达进行上调.
- 抑制PDK3增强了CD8+T细胞介导的细胞毒性,并且与PD-1阻断相结合,显著抑制瘤生长并改善小鼠模型中的存活率.
结论:
- PDK3通过调节瘤信号通路和免疫规避机制,在结肠癌的进展中发挥着关键作用.
- 准PDK3,特别是与抗PD-1等免疫检查点抑制剂相结合,代表了结肠癌的有希望的治疗策略.
相关概念视频
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:27Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
02:15M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K